Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 19,593 | 10,884 | 4,101 | 749 | 0 |
| Cost of Goods | 8,978 | 6,836 | 10,718 | 282 | N/A |
| Gross Profit | 10,615 | 4,048 | -6,617 | 467 | N/A |
| Operating Expenses | 31,477 | 57,440 | 65,106 | 49,802 | 18,858 |
| Operating Income | -19,884 | -52,556 | -71,005 | -49,053 | -18,858 |
| Interest Expense | 1,419 | 3,131 | 3,914 | 3,109 | 0 |
| Other Income | 6,838 | 25,600 | 3,852 | 309 | 252 |
| Pre-tax Income | -14,465 | -30,087 | -71,067 | -51,853 | -18,606 |
| Income Tax | N/A | -4,675 | N/A | N/A | N/A |
| Net Income Continuous | -14,465 | -25,412 | -71,067 | -51,853 | -18,606 |
| Net Income | $-14,465 | $-25,412 | $-71,067 | $-51,853 | $-18,606 |
| EPS Basic Total Ops | -6.71 | -58.79 | -1,464.20 | -1,220.00 | -760.00 |
| EPS Basic Continuous Ops | -6.71 | -58.79 | -1,464.21 | -1,224.64 | -752.78 |
| EPS Diluted Total Ops | -6.71 | -58.79 | -1,464.20 | -1,220.00 | -760.00 |
| EPS Diluted Continuous Ops | -6.71 | -58.79 | -1,464.21 | -1,224.64 | -752.78 |
| EPS Diluted Before Non-Recurring Items | -9.84 | -92.00 | -1,540.00 | -1,220.00 | -760.00 |
| EBITDA(a) | $-18,435 | $-49,053 | $-67,121 | $-47,436 | $-18,695 |